4//SEC Filing
Danos Olivier 4
Accession 0001562180-24-006013
CIK 0001590877other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 6:38 PM ET
Size
7.3 KB
Accession
0001562180-24-006013
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Danos Olivier
Chief Scientific Officer
Transactions
- Award
Common Stock
2024-06-28$9.95/sh+1,363$13,555→ 126,216 total - Award
Common Stock
2024-08-01+58,867→ 185,083 total
Footnotes (3)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the REGENXBIO Inc. Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of January 1, 2024 through June 30, 2024. This transaction is exempt under Rule 16b-3(c).
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on June 28, 2024.
- [F3]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of February 1, 2025, August 1, 2025, February 1, 2026 and August 1, 2026 while the recipient provides continuous service to the Issuer.
Documents
Issuer
REGENXBIO Inc.
CIK 0001590877
Entity typeother
Related Parties
1- filerCIK 0001701180
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 6:38 PM ET
- Size
- 7.3 KB